Ambalal Sarabhai Enterprises Limited (NSE:AMBALALSA)

Market Cap	2.41B -12.2%
Revenue (ttm)	2.03B +2.6%
Net Income	178.04M +261.0%
EPS	2.32 +262.5%
Shares Out	n/a
PE Ratio	13.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,679
Open	31.10
Previous Close	30.94
Day's Range	30.81 - 32.39
52-Week Range	30.30 - 38.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About NSE:AMBALALSA

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Am...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 547
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMBALALSA

Financial Performance

In fiscal year 2026, NSE:AMBALALSA's revenue was 2.03 billion, an increase of 2.64% compared to the previous year's 1.97 billion. Earnings were 178.04 million, an increase of 261.05%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 22, 2026

Data Sources Report a data error